HOSPITAL-ACQUIRED DISEASE TESTING MARKET ANALYSIS

Hospital-Acquired Disease Testing MarketSize and Trends

Hospital-acquired Disease Testing Market – Market Insights

The global hospital-acquired disease testing market is expected to be valued at US$ 925.4 million in 2019, and is expected to exhibit a CAGR of 20.0% over the forecast period (2019-2027).

Figure 1. Global Hospital-acquired Disease Testing Market Value (US$ Mn), by Region, 2019

Source: Coherent Market Insights Analysis (2020)

Increasing incidence of hospital acquired infections is expected to propel the market growth over the forecast period

Rising incidence of infections such as central line associated bloodstream infection (CLABSI), catheter-related bloodstream infection (CRBSI), and others are expected to drive growth of the hospital-acquired disease testing market over the forecast period. For instance, according to data published during the National Healthcare Safety Network Bloodstream Infection Surveillance in March 2018, around 30,000 CLABSI cases are reported every year in the U.S. CLABSI can prolong the hospital stay, which can increase the cost burden on patients and also lead to mortality.

Figure 2. Global Hospital-acquired Disease Testing Market Value, (US$ Million), 2016-2027

Source: Coherent Market Insights Analysis (2020)